SciSparc

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch SciSparc and buy or sell other stocks, ETFs, and their options commission-free!

About SPRC

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. 

CEO
Oz Adler
CEOOz Adler
Employees
2
Employees2
Headquarters
Tel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded
2004
Founded2004
Employees
2
Employees2

SPRC Key Statistics

Market cap
3.52M
Market cap3.52M
Price-Earnings ratio
-3.32
Price-Earnings ratio-3.32
Dividend yield
Dividend yield
Average volume
238.50K
Average volume238.50K
High today
$0.3199
High today$0.3199
Low today
$0.30
Low today$0.30
Open price
$0.31
Open price$0.31
Volume
344.11K
Volume344.11K
52 Week high
$1.79
52 Week high$1.79
52 Week low
$0.197
52 Week low$0.197

People also own

Based on the portfolios of people who own SPRC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.